Literature DB >> 22995365

Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens.

Manuel Parra-Sánchez1, Jose Carlos Palomares, Samuel Bernal, María Trinidad González, Nieves Sivianes, Luis Pérez, Isabel Pueyo, Estrella Martín-Mazuelos.   

Abstract

We have evaluated 696 samples (488 swabs and 208 urine specimens) with the cobas 4800 (c4800) CT/NG Test for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in swab and urine specimens. c4800 results were compared with those obtained from COBAS AMPLICOR (CAM) CT/NG Test. Discordant results were reanalyzed with the MultiNA system and compared with clinical data. For C. trachomatis detection by both methods, we obtained 93.8%, 100%, 100%, and 99.1% for sensitivity, specificity, and positive and negative predictive values, respectively. For urine specimens analyzed in c4800, our results were 96.6%, 100%, 100%, and 99.4%, respectively. For N. gonorrhoeae detection, swab results were:88.0%, 100%, 100%, and 99.4%. For urine specimen, results obtained were 100%, 100%, 100%, and 100%. Reanalyses were all concordant between both methods. c4800 results were comparable with those obtained with the CAM system. We had an excellent correlation between swab and urine specimens analyzed by c4800.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22995365     DOI: 10.1016/j.diagmicrobio.2012.08.004

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Neisseria gonorrhoeae false-positive result obtained from a pharyngeal swab by using the Roche cobas 4800 CT/NG assay in New Zealand in 2012.

Authors:  Arlo Upton; Collette Bromhead; David M Whiley
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

2.  Men and Women Have Similar Neisseria gonorrhoeae Bacterial Loads: a Comparison of Three Anatomical Sites.

Authors:  Brian M J W van der Veer; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers; Lieke B van Alphen; Petra F G Wolffs
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

3.  Despite Excellent Test Characteristics of the cobas 4800 CT/NG Assay, Detection of Oropharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae Remains Challenging.

Authors:  J M van Niekerk; B M J W van der Veer; C J P A Hoebe; J van de Bovenkamp; C van Herk; I H M van Loo; L B van Alphen; P F G Wolffs
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

4.  A multiplexed microfluidic PCR assay for sensitive and specific point-of-care detection of Chlamydia trachomatis.

Authors:  Deborah Dean; Rosemary S Turingan; Hans-Ulrich Thomann; Anna Zolotova; James Rothschild; Sandeep J Joseph; Timothy D Read; Eugene Tan; Richard F Selden
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  Evaluation of the Versant CT/GC DNA 1.0 assay (kPCR) for the detection of extra-genital Chlamydia trachomatis and Neisseria gonorrhoeae infections.

Authors:  Antonella Marangoni; Claudio Foschi; Paola Nardini; Monica Compri; Roberto Cevenini
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 6.  Chlamydia trachomatis as a Current Health Problem: Challenges and Opportunities.

Authors:  Rafaela Rodrigues; Carlos Sousa; Nuno Vale
Journal:  Diagnostics (Basel)       Date:  2022-07-25

7.  Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study.

Authors:  Pengcheng Huai; Furong Li; Zhen Li; Lele Sun; Xi'an Fu; Qing Pan; Gongqi Yu; Zemin Chai; Tongsheng Chu; Zihao Mi; Fangfang Bao; Honglei Wang; Bingni Zhou; Chuan Wang; Yonghu Sun; Guiye Niu; Yuan Zhang; Fanghui Fu; Xiaoqiao Lang; Xiaoling Wang; Hui Zhao; Daina Liu; Hong Liu; Dianchang Liu; Jian Liu; Aiqiang Xu; Furen Zhang
Journal:  BMC Infect Dis       Date:  2018-10-26       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.